Free Trial

SNDL (SNDL) Competitors

SNDL logo
$1.54 -0.02 (-1.28%)
Closing price 04:00 PM Eastern
Extended Trading
$1.54 0.00 (0.00%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SNDL vs. ACB, CGC, CRON, OGI, TLRY, ETNB, SDGR, JANX, VERA, and TVTX

Should you be buying SNDL stock or one of its competitors? The main competitors of SNDL include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), Tilray Brands (TLRY), 89BIO (ETNB), Schrodinger (SDGR), Janux Therapeutics (JANX), Vera Therapeutics (VERA), and Travere Therapeutics (TVTX). These companies are all part of the "pharmaceutical products" industry.

SNDL vs. Its Competitors

Aurora Cannabis (NASDAQ:ACB) and SNDL (NASDAQ:SNDL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

In the previous week, Aurora Cannabis had 2 more articles in the media than SNDL. MarketBeat recorded 4 mentions for Aurora Cannabis and 2 mentions for SNDL. Aurora Cannabis' average media sentiment score of 0.56 beat SNDL's score of 0.47 indicating that Aurora Cannabis is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aurora Cannabis
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SNDL
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

SNDL has a consensus price target of $4.00, suggesting a potential upside of 159.74%. Given SNDL's higher probable upside, analysts clearly believe SNDL is more favorable than Aurora Cannabis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
3.67
SNDL
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Aurora Cannabis has a beta of 1.75, indicating that its stock price is 75% more volatile than the S&P 500. Comparatively, SNDL has a beta of 3.4, indicating that its stock price is 240% more volatile than the S&P 500.

Aurora Cannabis has a net margin of 1.32% compared to SNDL's net margin of -11.48%. Aurora Cannabis' return on equity of 0.13% beat SNDL's return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis1.32% 0.13% 0.10%
SNDL -11.48%-9.02%-7.60%

47.6% of Aurora Cannabis shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Aurora Cannabis has higher earnings, but lower revenue than SNDL. SNDL is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora Cannabis$246.72M1.03$1.63M$0.1141.18
SNDL$671.81M0.60-$69.18M-$0.29-5.31

Summary

Aurora Cannabis beats SNDL on 13 of the 16 factors compared between the two stocks.

Get SNDL News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNDL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNDL vs. The Competition

MetricSNDLMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$409.93M$10.12B$5.52B$9.41B
Dividend YieldN/A2.05%3.80%4.04%
P/E RatioN/A16.5928.0419.84
Price / Sales0.6029.60429.5399.59
Price / CashN/A22.2635.8457.94
Price / Book0.493.578.125.65
Net Income-$69.18M$235.43M$3.25B$258.00M
7 Day Performance10.79%-1.67%0.97%2.09%
1 Month Performance21.26%2.91%7.36%11.13%
1 Year Performance-26.49%-16.44%31.31%18.40%

SNDL Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNDL
SNDL
1.4176 of 5 stars
$1.54
-1.3%
$4.00
+159.7%
-28.4%$409.93M$671.81M-5.312,516Gap Up
ACB
Aurora Cannabis
0.3883 of 5 stars
$4.58
+2.0%
N/A-23.4%$257.44M$246.72M41.641,130
CGC
Canopy Growth
0.4488 of 5 stars
$1.17
+3.5%
N/A-85.1%$215.13M$225.65M-0.293,150Positive News
CRON
Cronos Group
2.0851 of 5 stars
$2.07
-1.0%
N/A-16.3%$798.36M$117.61M15.92450
OGI
Organigram Global
0.8702 of 5 stars
$1.48
+2.1%
N/A-13.6%$198.23M$117.47M14.80860
TLRY
Tilray Brands
1.8639 of 5 stars
$0.66
+13.1%
$1.92
+191.8%
-67.8%$661.07M$788.94M-0.632,650
ETNB
89BIO
1.924 of 5 stars
$11.12
+1.1%
$26.43
+137.7%
+22.7%$1.62BN/A-3.2940News Coverage
Insider Trade
SDGR
Schrodinger
1.8305 of 5 stars
$21.14
+0.6%
$32.75
+54.9%
-6.6%$1.55B$207.54M-8.04790News Coverage
JANX
Janux Therapeutics
2.0145 of 5 stars
$26.18
+4.1%
$91.89
+251.0%
-36.8%$1.55B$9.34M-19.2530News Coverage
VERA
Vera Therapeutics
4.1061 of 5 stars
$23.78
-0.2%
$65.00
+173.3%
-32.5%$1.52BN/A-7.9340
TVTX
Travere Therapeutics
3.7272 of 5 stars
$16.91
+2.7%
$32.14
+90.1%
+60.4%$1.50B$233.18M-6.02460News Coverage
Analyst Revision

Related Companies and Tools


This page (NASDAQ:SNDL) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners